EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

EEDGAR/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Groups
  • Trending
  • News

More

  • Pricing
  • Community
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice. EDGAR is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. EDGAR/calls is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Pulling SEC filings + quote and writing the call…

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity
← New search
Home›Stocks›CVM

CVM

CEL SCI CORP

Next earnings Aug 12, 2026

Hold
$1.11
▲ +13.92%
$1.11▼ -54.88%
over 1Y
L $0.97EODHDH $13.04
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+13.9%
1W+9.9%
1M-21.3%
3M-65.3%
YTD-78.4%
1Y-54.9%
OverviewFinancialsValuationQualityTimelineFilings
Rating
Hold
Quality
D
Valuation
Fair value
Filings
Watch
Hold
Conviction
Horizon
Medium (3–12mo)
Street · 5 analysts
Buy

Revenue grew 65.5% YoY; but unprofitable (net margin -9624.2%).

Revenue (FY2014) $264K · FY2014

CEL SCI CORP shows $264K in FY2014 revenue (+65.5% YoY), a -9624.2% net margin, and -159.2% ROE.

Financials · annual, by fiscal year

Line itemFY21FY22FY23FY24FY25
Revenue—————
Gross profit—————
Operating income-$36.2M-$36.1M-$31.5M-$26.4M-$24.8M
Net income-$36.4M-$36.7M-$32.4M-$26.9M-$25.4M
Diluted EPS-$0.90-$0.87-$0.73-$15.31-$6.27
Net margin—————

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value-$1.62M
EV / EBITDA—
EV / Sales-6.1
EV / FCF—
P / FCF—
PEG (trailing)—
Earnings yield-272.3%
FCF yield-183.8%

Quality & risk

ROIC (est.)-122.8%
Free cash flow-$17.2M
Total debt—
Net cash$11.0M
Altman Z-Score-28.99 distress
Piotroski F-Score5/7

Capital returns

Buyback yield—
Dividend yield (est.)—
Shareholder yield—
Shares Δ YoY-83.2%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timeline

SEC · 8-Ks + reports
Some governance/structural items recently, but no outright red flags.
  1. 8-K Material agreement2026-06-16
  2. 10-Q Quarterly report2026-05-15
  3. 8-K Material agreement2026-05-14
  4. 8-K Material agreement2026-05-13
  5. S-1/A Securities registration2026-05-01
  6. S-1 Securities registration2026-04-17
  7. 10-Q Quarterly report2026-02-17
  8. 10-K Annual report2025-12-29
  9. 8-K Material event2025-11-24

Recent filings

all on EDGAR ↗
8-KPeriod ending 2026-06-142026-06-16open ↗424B5Filing2026-06-15open ↗RWFiling2026-05-27open ↗RWFiling2026-05-19open ↗4Period ending 2026-05-142026-05-18open ↗10-QPeriod ending 2026-03-312026-05-15open ↗8-KPeriod ending 2026-05-112026-05-14open ↗4Period ending 2026-05-132026-05-14open ↗8-KPeriod ending 2026-05-112026-05-13open ↗424B4Filing2026-05-13open ↗EFFECTFiling2026-05-11open ↗CORRESPFiling2026-05-07open ↗

Quality score

D
ValueGrowthProfitHealthMom.
ValueF
GrowthB+
ProfitabilityF
Financial healthC+
Momentum—
  • ✓Revenue growing year-over-year
  • ✗Profitable (positive net income)
  • ✗Net margin above 10%
  • ✗Return on equity above 15%
  • ✓Liabilities below 2× equity
Revenue
$264K
+65.5% YoY
Net margin
-9624.2%
ROE
-159.2%
P/E
—

SEC fundamentals · FY 2025

■ revenue · ■ net income, by fiscal year

Revenue$264K+65.5%
Net income-$25.4M+5.6%
Operating income-$24.8M+5.9%
Diluted EPS-$6.27+59.0%
Cash & equivalents$11.0M+131.2%
Total assets$28.2M+4.3%
Total liabilities$12.2M-13.6%
Stockholders' equity$16.0M+24.0%
Op.: -9396.5%L/E: 0.76x

Frequently asked

Is CEL SCI CORP (CVM) a buy?
CVM currently carries a Hold rating with 2/5 conviction, derived from its latest SEC filings. Revenue grew 65.5% YoY; but unprofitable (net margin -9624.2%).
What is CEL SCI CORP's quality score?
CVM scores 43.8235294117647/100 (grade D) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0000725363, latest 10-Q filed 2026-05-15) · EODHD · as of 6/22/2026, 11:38:33 PM.

Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Insider activity

Form 4 · SEC

Last 90 days: 2 open-market buys · 0 sales

2026-05-14
KERSTEN GEERT R
Chief Executive Officer
Buy300K @ $1.20$360K
2026-05-13
KERSTEN GEERT R
Chief Executive Officer
Buy100K @ $1.19$119K
2026-03-31
TALOR EYAL
Chief Scientific Officer
Award747.00 @ $3.21$2.40K
2026-03-31
PRICHEP PATRICIA B
Chief Financial Officer
Award1.34K @ $3.21$4.29K
2026-03-31
KERSTEN GEERT R
Chief Executive Officer
Award1.68K @ $3.21$5.40K
2026-01-22
KERSTEN GEERT R
Chief Executive Officer
Buy38.0K @ $5.26$200K
2025-12-31
TALOR EYAL
Chief Scientific Officer
Award456.00 @ $5.26$2.40K
2025-12-31
PRICHEP PATRICIA B
Chief Financial Officer
Award815.00 @ $5.26$4.29K

Dividends

Irregular
Yield (TTM)
—
Annual / share
—
Last ex-date
1996-08-28
Last amount
$62.50
ex 1996-08-28$62.50

Source: EODHD. Yield = trailing-12-month dividends ÷ price.

Recent news

market news →
Why Harmonic Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving PremarketBullish
finance.yahoo.com· 2026-05-13
CEL-SCI prices $7.2M offering at $1.20 per share
seekingalpha.com· 2026-05-12
Cel-Sci reports FY resultsBearish
seekingalpha.com· 2025-12-30
After-Hours Trading Sees Sharp Gains Across Emerging Growth NamesBullish
nasdaq.com· 2025-09-19
Thursday's session: top gainers and losersBullish
chartmill.com· 2025-08-28
Let's take a look at the stocks that are in motion in today's session.Bullish
chartmill.com· 2025-08-28

Vs tracked universe

compare →

1044 tracked peers · median

EDGAR Score44 vs 67
Revenue growth65.5% vs 7.1%
Net margin-9624.2% vs 10.5%
Return on equity-159.2% vs 12.3%
P/E— vs 25.5

News sentiment

EODHD · 2d
Bearish
-0.28
vs typical · 2 articles
↑ improving

Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.